Pliva ANDA Approvals On Hold Following FDA Warning Letter

 
• By Todd Leeuwenburgh

Deliveries will not be interrupted by GMP violations at Zagreb, Croatia facility, Pliva says.

More from Archive

More from Pink Sheet